Evidence map›Paper›PMID 41125747›Full record

ArticleScientific reports2025

Clinical Characteristics and Outcomes of a Cohort of Multiethnic Asian Patients with Cardiac Myxoma.

Irving Yu Le Shua, Pavarisa Tongboriboon, Faith Sim, Tony Yw Li, Kian-Keong Poh, William Kf Kong, Mark Y Chan, Ping Chai, Tiong Cheng Yeo, Leonard Ll Yeo and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Irving Yu Le Shua *Department of Medicine, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Pavarisa Tongboriboon *Department of Medicine, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Faith SimDepartment of Cardiology, National University Heart Centre Singapore, Singapore, Singapore.
Tony Yw LiDepartment of Cardiology, National University Heart Centre Singapore, Singapore, Singapore.
Kian-Keong PohDepartment of Cardiology, National University Heart Centre Singapore, Singapore, Singapore.
William Kf KongDepartment of Cardiology, National University Heart Centre Singapore, Singapore, Singapore.
Mark Y ChanDepartment of Cardiology, National University Heart Centre Singapore, Singapore, Singapore.
Ping ChaiDepartment of Cardiology, National University Heart Centre Singapore, Singapore, Singapore.
Tiong Cheng YeoDepartment of Cardiology, National University Heart Centre Singapore, Singapore, Singapore.
Leonard Ll YeoDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Benjamin Yq TanDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Hon Jen WongDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Yao Hao TeoDepartment of Medicine, National University Hospital, Singapore, Singapore.
Ching-Hui SiaDepartment of Cardiology, National University Heart Centre Singapore, Singapore, Singapore. ching_hui_sia@nuhs.edu.sg.ORCID http://orcid.org/0000-0002-2764-2869

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac myxomas are the most common primary cardiac tumours. The overall prevalence is very low and up to 25% present asymptomatically. In Asia, the data on myxomas is limited. Therefore, we aimed to outline a multi-ethnic Asian population of cardiac myxoma patients. We included all index echocardiographic diagnoses of myxoma at a tertiary cardiovascular referral centre from May 2004 to April 2021. A retrospective review of all patients' medical records was conducted. Data including patient characteristics, clinical presentation, imaging, treatment, and outcomes were collected and analysed. A total of 64 patients (mean age 66.4 years old, male 61%) were diagnosed with cardiac myxoma. The incidence of major adverse cardiovascular events (MACE) was 10 (16.1%) and 10-year mortality was 11 (17.2%). The proportion of asymptomatic patients (30.2%) increased from 15.4% before 2012 to 35.3% after 2012. Pre-existing chronic kidney disease and ischaemic heart disease were independently associated with increased risk of mortality and MACE (p-values < 0.05). Most patients (75.0%) underwent surgical resection. This was associated with a decreased risk of mortality and MACE (p-values < 0.05). The increase in the diagnosis of asymptomatic patients over the years could be attributed to increased opportunistic screening and incidental pickups. Surgical resection was associated with better outcomes. However, the poor outcomes of non-operated patients may be due to the concurrent comorbidities that preclude surgery.

Indexed as

Heart NeoplasmsMyxomaAgedAged, 80 and overAsian PeopleEchocardiographyFemaleHumansMaleMiddle AgedRetrospective StudiesAsymptomaticCardiac myxomaCardiac surgeryClinical characteristicsMajor adverse cardiovascular eventsMortality

Identifiers

PMID41125747
PMCPMC12546708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.